Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 21 strange trades.

Benzinga

With Roe in doubt, some fear tech surveillance of pregnancy

Companies that collect data from the digital clues people leave online often know their most sensitive health information _ gleaned from web searches, health apps and location trackers

The Independent UK

With Roe in doubt, some fear tech surveillance of pregnancy

Companies that collect data from the digital clues people leave online often know their most sensitive health information _ gleaned from web searches, health apps and location trackers

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Gov won't say if Paxlovid is accessible

Officials won't say how many people have received antiviral pills, or if they're being equitably distributed

Salon

Ohio Lawyer Says Pharmacy Distributors To Pay $878M For Opioid Epidemic

A lawyer for two Ohio counties said that CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance Inc (NASDAQ:WBA), and Walmart Inc (NYSE:WMT) should fund an $878 million plan addressing the opioid crisis, writes Reuters. In November, a federal jury decided that the companies created a public nuisance by flooding Ohio's Lake and Trumbull counties with addictive prescription pain…

Benzinga

Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales

CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the US

The Independent UK

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

CVS, Walgreens and Walmart Were found to recklessly dispense narcotic painkillers in two Ohio counties, fueling a drug epidemic

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

Benzinga

Judge to decide abatement amounts in opioid pharmacy case

A hearing will begin Tuesday in federal court in Cleveland that will result in a judge determining how much CVSHealth, Walgreens Co. and Walmart Corp. should pay two northeast Ohio counties to help them abate the continuing opioid crisis

The Independent UK

Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales

CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the US

The Independent UK

Walgreens reaches $683m settlement with Florida over role in opioid crisis

The company settled over claims that it exacerbated the opioid crisis in the Sunshine State.

The Independent UK

Where CVS Health Stands With Analysts

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter:

Benzinga

CVS Health's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, CVS Health (NYSE:CVS) earned $2.31 billion, a 78.47% increase from the preceding quarter. CVS Health also posted a total of $76.83 billion in sales, a 0.29% increase since Q4.

Benzinga

Want free, at-home COVID-19 tests from pharmacies and insurers? It’s not always easy, despite requirements

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

Chicago Tribune

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

CVS Health Q1 Earnings Beat Street Expectations, Raises FY22 Adjusted EPS Forecast

CVS Health Corp's (NYSE:CVS) Q1 sales increased 11.2% Y/Y to $76.83 billion, beating the consensus of $75.39 billion. Adjusted operating income increased 6.6% to $4.48 billion primarily due to increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of COVID-19 vaccinations in the Retail/LTC…

Benzinga

CVS Health: Q1 Earnings Insights

CVS Health (NYSE:CVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Chicago Tribune

Commentary: How can bricks-and-mortar stores beat online sellers? Allow dogs

When I learned that our corner CVS and Ace Hardware didn’t prohibit customers from bringing their dogs along while shopping, I switched to these stores.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

How Markets Are Playing CVS Health, T-Mobile US

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.

Benzinga

$100 Invested In CVS Health 20 Years Ago Would Be Worth This Much

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 9.11%. Currently, CVS Health has a market capitalization of $126.21 billion.

Tribune News Service

Editorial: Feds need to ramp up COVID treatment

The nation’s response to the pandemic has taken on a new phase, as mask mandates and social distancing give way to home-based testing and outpatient treatments. That’s why it’s essential the Biden administration get its new “test-to-treat” program up to speed. With new infections rising in Florida and nationally, the…

StockNews.com

5 Stocks to Buy Now if You Think We're Headed for a Bear Market

High inflation, intensifying supply chain disruptions, and rising energy prices are leading to a market downturn. Therefore, it could be wise to bet on non-cyclical stocks Diageo (DEO), PepsiCo (PEP), Unilever (UL), CVS Health (CVS), and Altria Group (MO), which are expected to survive a bear market because of the…

Benzinga

Here's How Much $1000 Invested In CVS Health 20 Years Ago Would Be Worth Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.37% on an annualized basis producing an average annual return of 9.55%. Currently, CVS Health has a market capitalization of $135.84 billion.

Tribune News Service

How the test-to-treat pillar of the US COVID strategy is failing patients

The federal “test-to-treat” program, announced in March, is meant to reduce COVID-19 hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don’t have access to the program.

The Independent UK

Baby formula shortage: What is causing supply issue and which stores are rationing products?

Out-of-stock per centages reached higher than 40 per cent in seven states in first week of April

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.